Dr. Hönle AG: Hoenle Group adjusts forecast for financial year 2024/25

Gilching (pta011/05.08.2025/08:55 UTC+2)

The Management Board had expected revenue of €95 million to €105 million for the Hoenle Group in the 2024/25 financial year and an operating result before depreciation and amortization (EBITDA) significantly higher than the adjusted EBITDA of the previous year (€5.5 million).

Based on current information, the Management Board expects the Hoenle Group to generate revenue of between €92 million and €94 million in fiscal year 2024/25 (PY: €98.7 million). Due to the cost-cutting measures initiated, it expects an operating result before depreciation and amortization (EBITDA) of between €5 million and €6 million (PY adjusted EBITDA: €5.5 million) despite the lower revenue level.

Dr. Hoenle AG will publish its Q3 statement for financial year 2024/25 on August 7, 2025, as planned.

About Hönle

The Dr. Hönle AG is a listed technology company based in Gilching. The Hönle Group develops innovative solutions with a focus on UV technology for a wide range of industrial applications with its 600 employees. A business unit includes the development and sale of industrial adhesives and adhesive curing devices. The company also produces drying systems for the printing and coating industry. Another business area deals with the environmentally friendly disinfection of water, air and surfaces. The Hönle Group supplies technology and global market leaders worldwide and is represented in over 20 countries with its own companies and partner companies.

(end)

Emitter:	Dr. Hönle AG Nicolaus-Otto-Str. 2 82205 Gilching Germany
Contact Person:	Peter Weinert
Phone:	+49 8105 2083 173
E-Mail:	peter.weinert@hoenle.de
Website:	www.hoenle.de
ISIN(s):	DE0005157101 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate